Animation - Including Everyone in Clinical Trials for Myelodysplastic Syndromes (MDS)
This animation provides an overview of the importance of including everyone in clinical trials for myelodysplastic syndromes (MDS). Researchers are working hard on new ways to screen for, diagnose, and treat MDS for everyone. However, only 6 in every 100 people with all types of cancer volunteer for a clinical trial. Some research suggests that people of different ethnicities may tend to develop different types of MDS. This can affect diagnosis and treatment for people from each group. Therefore to know what is most effective, MDS clinical trials need diverse participants and it is important for all groups to take part in clinical trials. Watch to learn about how clinical trials can offer everyone with MDS the chance to try treatments that are not yet available to the public. Be sure to ask your doctor about how taking part in an MDS clinical trial can help you and help researchers learn about safety and effectiveness of new MDS treatments and improve care for everyone.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
Animation - Including Everyone in Clinical Trials for MDS
Slide Show - Including Everyone in Clinical Trials for MDS
1.
Why is diversity important in MDS clinical trials? What benefits do diverse clinical trials provide?
2.
Why are some MDS patients not participating in clinical trials? What are the barriers to enrollment?
3.
If I feel uncomfortable during a clinical trial am I obligated to participate?
4.
How can I find an MDS clinical trial that is appropriate for me?
